The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Functional Study of CD4+CD25+ Regulatory T Cells in Health and Autoimmune Hepatitis
Abstract
Regulatory CD4+CD25+ T cells (Tregs) are defective numerically and functionally in autoimmune hepatitis (AIH). We have investigated and compared the mechanism of action of Tregs in healthy subjects and in AIH patients using Transwell experiments, where Tregs are cultured either in direct contact with or separated from their targets by a semipermeable membrane. We also studied Treg FOXP3 expression and effect on apoptosis. Direct contact is necessary for Tregs to suppress proliferation and IFN-γ production by CD4+CD25− and CD8+ T cells in patients and controls. Moreover, in both, direct contact of Tregs with their targets leads to increased secretion of regulatory cytokines IL-4, IL-10, and TGF-β, suggesting a mechanism of linked immunosuppression. Tregs/CD4+CD25− T cell cocultures lead to similar changes in IFN-γ and IL-10 secretion in patients and controls, whereas increased TGF-β secretion is significantly lower in patients. In contrast, in patients, Tregs/CD8+ T cell cocultures lead to a higher increase of IL-4 secretion. In AIH, Treg FOXP3 expression is lower than in normal subjects. Both in patients and controls, FOXP3 expression is present also in CD4+CD25− T cells, although at a low level and not associated to suppressive function. Both in patients and controls, addition of Tregs does not influence target cell apoptosis, but in AIH, spontaneous apoptosis of CD4+CD25− T cells is reduced. In conclusion, Tregs act through a direct contact with their targets by modifying the cytokine profile and not inducing apoptosis. Deficient CD4+CD25− T cell spontaneous apoptosis may contribute to the development of autoimmunity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Foxp3 programs the development and function of CD4+CD25+ regulatory T cells
Fontenot, J. D., Gavin, M. A., & Rudensky, A. Y. (2003) · Nature Immunology · doi:10.1038/ni904 · Cited by 7,745
Sakaguchi, S. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141122 · Cited by 3,306
Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis
Watanabe-Fukunaga, R., Brannan, C. I., Copeland, N. G., Jenkins, N. A., & Nagata, S. (1992) · Nature · doi:10.1038/356314a0 · Cited by 2,885
An essential role for Scurfin in CD4+CD25+ T regulatory cells
Khattri, R., Cox, T., Yasayko, S.-A., & Ramsdell, F. (2003) · Nature Immunology · doi:10.1038/ni909 · Cited by 2,856
Thornton, A. M., & Shevach, E. M. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.2.287 · Cited by 2,639
CD4+CD25+ suppressor T cells: more questions than answers
Shevach, E. M. (2002) · Nature Reviews Immunology · doi:10.1038/nri821 · Cited by 2,110
Wildin, R. S., Ramsdell, F., Peake, J., Faravelli, F., Casanova, J.-L., Buist, N., Levy-Lahad, E., Mazzella, M., Goulet, O., Perroni, L., et al. (2001) · Nature Genetics · doi:10.1038/83707 · Cited by 1,922
CD4+CD25high Regulatory Cells in Human Peripheral Blood
Baecher-Allan, C., Brown, J. A., Freeman, G. J., & Hafler, D. A. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.3.1245 · Cited by 1,859
Generalized lymphoproliferative disease in mice, caused by a point mutation in the fas ligand
Takahashi, T., Tanaka, M., Brannan, C. I., Jenkins, N. A., Copeland, N. G., Suda, T., & Nagata, S. (1994) · Cell · doi:10.1016/0092-8674(94)90375-1 · Cited by 1,528
Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25– T cells
R.Walker, M., Kasprowicz, D. J., Gersuk, V. H., Bènard, A., Van Landeghen, M., Buckner, J. H., & Ziegler, S. F. (2003) · Journal of Clinical Investigation · doi:10.1172/jci19441 · Cited by 1,245
Chatila, T. A., Blaeser, F., Ho, N., Lederman, H. M., Voulgaropoulos, C., Helms, C., & Bowcock, A. M. (2000) · Journal of Clinical Investigation · doi:10.1172/jci11679 · Cited by 940
Autoimmune Hepatitis in Childhood: A 20–Year Experience
Gregorio, G. V., Portmann, B., Reid, F., Donaldson, P. T., Doherty, D. G., McCartney, M., Mowat, A. P., Vergani, D., & Mieli-Vergani, G. (1997) · Hepatology · doi:10.1002/hep.510250308 · Cited by 665
Self-citationVieira, P. L., Christensen, J. R., Minaee, S., O’Neill, E. J., Barrat, F. J., Boonstra, A., Barthlott, T., Stockinger, B., Wraith, D. C., & O’Garra, A. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.10.5986 · Cited by 654
Nakamura, K., Kitani, A., Fuss, I., Pedersen, A., Harada, N., Nawata, H., & Strober, W. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.2.834 · Cited by 630
Human CD4+CD25+ cells: a naturally occurring population of regulatory T cells
Ng, W. F., Duggan, P. J., Ponchel, F., Matarese, G., Lombardi, G., Edwards, A. D., Isaacs, J. D., & Lechler, R. I. (2001) · Blood · doi:10.1182/blood.v98.9.2736 · Cited by 609
Sugiyama, H., Gyulai, R., Toichi, E., Garaczi, E., Shimada, S., Stevens, S. R., McCormick, T. S., & Cooper, K. D. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.1.164 · Cited by 570
CD25+ CD4+ T Cells Regulate the Expansion of Peripheral CD4 T Cells Through the Production of IL-10
Annacker, O., Pimenta-Araujo, R., Burlen-Defranoux, O., Barbosa, T. C., Cumano, A., & Bandeira, A. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.5.3008 · Cited by 552
Control of T‐cell activation by CD4+ CD25+ suppressor T cells
Shevach, E. M., McHugh, R. S., Piccirillo, C. A., & Thornton, A. M. (2001) · Immunological Reviews · doi:10.1034/j.1600-065x.2001.1820104.x · Cited by 546
Schmidt, D., Goronzy, J. J., & Weyand, C. M. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118638 · Cited by 482
Green, E. A., Gorelik, L., McGregor, C. M., Tran, E. H., & Flavell, R. A. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1834400100 · Cited by 446
Human anergic/suppressive CD4+CD25+ T cells: a highly differentiated and apoptosis-prone population
Taams, L. S., Smith, J., Rustin, M. H., Salmon, M., Poulter, L. W., & Akbar, A. N. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(200104)31:4<1122::aid-immu1122>3.0.co;2-p · Cited by 436
Expression of FOXP3 mRNA is not confined to CD4+CD25+ T regulatory cells in humans
Morgan, M. E., van Bilsen, J. H. M., Bakker, A. M., Heemskerk, B., Schilham, M. W., Hartgers, F. C., Elferink, B. G., van der Zanden, L., de Vries, R. R. P., Huizinga, T. W. J., et al. (2005) · Human Immunology · doi:10.1016/j.humimm.2004.05.016 · Cited by 418
Impairment of CD4+CD25+ regulatory T-cells in autoimmune liver disease
Longhi, M. S., Ma, Y., Bogdanos, D. P., Cheeseman, P., Mieli-Vergani, G., & Vergani, D. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.03.008 · Cited by 405
Self-citationLevine, B. L., Bernstein, W. B., Connors, M., Craighead, N., Lindsten, T., Thompson, C. B., & June, C. H. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.12.5921 · Cited by 340
De novo generation of antigen-specific CD4+CD25+regulatory T cells from human CD4+CD25–cells
Walker, M. R., Carson, B. D., Nepom, G. T., Ziegler, S. F., & Buckner, J. H. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407691102 · Cited by 285
Effect of CD4+CD25+ regulatory T-cells on CD8 T-cell function in patients with autoimmune hepatitis
Longhi, M. S., Ma, Y., Mitry, R. R., Bogdanos, D. P., Heneghan, M., Cheeseman, P., Mieli-Vergani, G., & Vergani, D. (2005) · Journal of Autoimmunity · doi:10.1016/j.jaut.2005.05.001 · Cited by 237
Self-citationPop, S. M., Wong, C. P., Culton, D. A., Clarke, S. H., & Tisch, R. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20042398 · Cited by 210
Drappa, J., Brot, N., & Elkon, K. B. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.21.10340 · Cited by 206
Schirmer, M., Vallejo, A. N., Weyand, C. M., & Goronzy, J. J. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.2.1018 · Cited by 191
CD4+ CD25+ CD62+ T-Regulatory Cell Subset Has Optimal Suppressive and Proliferative Potential
Fu, S., Yopp, A. C., Mao, X., Chen, D., Zhang, N., Chen, D., Mao, M., Ding, Y., & Bromberg, J. S. (2004) · American Journal of Transplantation · doi:10.1046/j.1600-6143.2003.00293.x · Cited by 187
Physiopathology and genetics of vitiligo
Passeron, T., & Ortonne, J.-P. (2005) · Journal of Autoimmunity · doi:10.1016/j.jaut.2005.10.001 · Cited by 163
Therapeutic vaccination using CD4 + CD25 + antigen-specific regulatory T cells
Bluestone, J. A., & Tang, Q. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405234101 · Cited by 156
Chtanova, T., Kemp, R. A., Sutherland, A. P. R., Ronchese, F., & Mackay, C. R. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.6.3057 · Cited by 128
Suto, A., Nakajima, H., Kagami, S., Suzuki, K., Saitō, Y., & Iwamoto, I. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.4.2010170 · Cited by 123
CD4+CD25+ T Cells Regulate Airway Eosinophilic Inflammation by Modulating the Th2 Cell Phenotype
Jaffar, Z. H., Sivakuru, T., & Roberts, K. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.6.3842 · Cited by 120
Nieves, D. S., Phipps, R. P., Pollock, S. J., Ochs, H. D., Zhu, Q., Scott, G., Ryan, C., Kobayashi, I., Rossi, T. M., & Goldsmith, L. A. (2004) · Archives of Dermatology · doi:10.1001/archderm.140.4.466 · Cited by 120
Diversity of regulatory CD4 +T cells controlling distinct organ-specific autoimmune diseases
Alyanakian, M., You, S., Damotte, D., Gouarin, C., Esling, A., Cordier, C., Havouis, S., Chatenoud, L., & Bach, J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2636971100 · Cited by 110
Human CD4 + CD25 + regulatory cells have marked and sustained effects on CD8 + T cell activation
Câmara, N. O. S., Sébille, F., & Lechler, R. I. (2003) · European Journal of Immunology · doi:10.1002/eji.200323966 · Cited by 97
Freeman, C. M., Chiu, B., Stolberg, V. R., Hu, J. S., Zeibecoglou, K., Lukacs, N. W., Lira, S. A., Kunkel, S. L., & Chensue, S. W. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.4.1962 · Cited by 89
Cytokine overproduction in healthy first degree relatives of patients with IDDM
Hussain, M. J., Maher, J. F., Warnock, T. M., Vats, A., Peakman, M., & Vergani, D. (1998) · Diabetologia · doi:10.1007/s001250050913 · Cited by 67
Self-citationImmune regulation by CD4+CD25+ regulatory T cells: implications for transplantation tolerance
Taams, L. S., Vukmanovic‐Stejic, M., Salmon, M., & Akbar, A. N. (2003) · Transplant Immunology · doi:10.1016/s0966-3274(03)00047-9 · Cited by 38
About CD4pos CD25pos regulatory cells
Asseman, C., & von Herrath, M. (2002) · Autoimmunity Reviews · doi:10.1016/s1568-9972(02)00054-x · Cited by 38
Dieckmann, D., Ploettner, H., Dotterweich, S., & Schuler, G. (2005) · Immunology · doi:10.1111/j.1365-2567.2005.02144.x · Cited by 38
Cited by
Fu, J., Xu, D., Liu, Z., Shi, M., Zhao, P., Fu, B., Zhang, Z., Yang, H., Zhang, H., Zhou, C., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.102 · Cited by 897
Afzali, B., Lombardi, G., Lechler, R. I., & Lord, G. M. (2007) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2007.03356.x · Cited by 762
Arruvito, L., Sanz, M., Banham, A. H., & Fainboim, L. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.4.2572 · Cited by 443
Mizukami, Y., Kono, K., Kawaguchi, Y., Akaike, H., Kamimura, K., Sugai, H., & Fujii, H. (2008) · International Journal of Cancer · doi:10.1002/ijc.23392 · Cited by 374
Human regulatory T cells: role in autoimmune disease and therapeutic opportunities
Brusko, T. M., Putnam, A. L., & Bluestone, J. A. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00637.x · Cited by 374
Metadata
- Authors
- Longhi, M. S., Hussain, M. J., Mitry, R. R., Arora, S. K., Mieli-Vergani, G., Vergani, D., & Ma, Y.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-04-01
- Volume
- 176
- Issue
- 7
- Pages
- 4484-4491
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1518082296
- Cited by
- 323
- References
- 43
- FWCI
- 17.16
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.